EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Coptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study

Chae-Yeon Kang iD, Yeon-Joo Yoo iD, Ji-Han Kim iD, Seung-Hoon Yoo, Hyun-Joo Kim, Min-Seong Lee iD, Byung-Cheol Lee iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188109 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Chae-Yeon Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Drugs, Chinese Herbal, Dyslipidemias, Obesity. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, diabetes, and dyslipidemia form an interconnected metabolic disease cluster driven by insulin resistance and chronic inflammation. This study evaluated the clinical efficacy and multi-target mechanisms of Coptidis Rhizoma for these metabolic disorders through an integrated systematic review, meta-analysis of randomized controlled trials (RCTs), network pharmacology, and molecular docking. Meta-analysis of 19 RCTs (n = 1718) demonstrated that Coptidis-containing formulations, primarily as adjunctive therapy, significantly improved primary clinical endpoints across all three metabolic conditions: body mass index (BMI: SMD = −0.72, 95% CI [−1.00, −0.44], p < 0.00001), glycated hemoglobin (HbA1c: SMD = −0.77, 95% CI [−1.07, −0.47], p < 0.00001), and low-density lipoprotein cholesterol (LDL-C: SMD = −1.10, 95% CI [−1.57, −0.62], p < 0.00001). Network analysis revealed shared targets enriched in lipid metabolism, inflammatory signaling, and PI3K-Akt/MAPK cascades. Molecular docking demonstrated favorable structural compatibility and predicted docking scores (ranging from −7.1 to −9.5 kcal/mol) of berberine toward key hub proteins, including PIK3CA, JAK2, MAOA, and PARP1. Consequently, Coptidis Rhizoma provides tangible clinical benefits across interconnected metabolic outcomes via the multi-target regulation of inflammatory and insulin signaling pathways. Clinically, Coptidis-containing formulations show promise as a complementary adjunct to conventional metabolic therapies, though future large-scale, standardized RCTs remain necessary to confirm long-term safety and optimize dosing regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDrugs, Chinese HerbalDyslipidemiasObesityHumansComputer SimulationCoptis chinensisMolecular Docking SimulationNetwork Pharmacology

Stichwörter der Autor:innen

Coptidis chinensisberberinedyslipidemiametabolic syndromemolecular dockingnetwork pharmacologysystematic reviewtype 2 diabetes mellitus

Substanzen

Coptidis rhizoma extractDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
  • Department of Nephrology & Endocrinology, Kyung Hee University Korean Medicine Hospital, Kyung Hee Medical Center, 23, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.

ORCID-Profile: Chae-Yeon Kang, Yeon-Joo Yoo, Ji-Han Kim, Min-Seong Lee, Byung-Cheol Lee

Förderung

  • Ministry of Health and Welfare

Zitieren

APA

Kang, C. Y., Yoo, Y. J., Kim, J. H., Yoo, S. H., Kim, H. J., Lee, M. S., & Lee, B. C. (2026). Coptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188109

Vancouver

Kang CY, Yoo YJ, Kim JH, Yoo SH, Kim HJ, Lee MS, et al. Coptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188109

BibTeX
@article{Kang2026,
  author = {Kang, Chae-Yeon and Yoo, Yeon-Joo and Kim, Ji-Han and Yoo, Seung-Hoon and Kim, Hyun-Joo and Lee, Min-Seong and Lee, Byung-Cheol},
  title = {Coptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188109}
}
Kostenlos starten →